News - Eisai

Filter

Current filters:

Eisai

Popular Filters

110 to 114 of 114 results

Public Citizen says US FDA should immediately pull Eisai and Pfizer’s high-dose Aricept from market

19-05-2011

US consumer watchdog Public Citizen has called for higher doses of Aricept (donepezil), marketed by originator…

AriceptEisaiNeurologicalNorth AmericaPfizerPharmaceuticalRegulation

Eisai gets Swiss approval for Halaven

19-05-2011

Japanese drug major Eisai (TYO: 4532), says that its Halaven(eribulin) has been approved for use in…

EisaiEuropeHalavenOncologyPharmaceuticalRegulation

US FDA not ready to approve Eisai Aricept Patch; Lipacreon and Halaven OKed in Japan

27-04-2011

Japanese drug major Eisai (TYO: 4523) says that the US Food and Drug Administration has issued a Complete…

AriceptAsia-PacificEisaiHalavenLipacreonNeurologicalNorth AmericaOncologyPfizerPharmaceuticalRegulation

Eisai debuts breast cancer drug Halaven in UK

20-04-2011

Japanese drug major Eisai (TYO: 4523) has launched its Halaven (eribulin), a novel treatment for patients…

EisaiEuropeHalavenMarkets & MarketingOncologyPharmaceutical

110 to 114 of 114 results

Back to top